Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse, Rat, Clawed frog|
|Host / Isotype||Chicken / IgY|
|Immunogen||Full length human BCAS2.|
|Purification||Antigen affinity chromatography|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Western Blot (WB)||1/500|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-20841 detects BCAS2 in human, mouse, rat and Xenopus laevis samples.
PA1-20841 has been successfully used in Western blot procedures.
The PA1-20841 immunogen is full length human BCAS2.
cDNA encoding BCAS2 has been isolated. The deduced 225-amino acid protein contains a central potential N-glycosylation site and multiple N-terminal potential phosphorylation sites. Northern and Southern blot analyses demonstrates expression of a 1.5-kb transcript at various levels in multiple breast cancer cell lines, with greatest amplification in BT-20 and MCF-7 cells. BCAS2 is ubiquitously expressed in normal tissues.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
breast carcinoma amplified sequence 2; breast carcinoma-amplified sequence 2; breast carcinoma-amplified sequence 2 homolog; DAM1; DNA amplified in mammary carcinoma 1 protein; pre-mRNA-splicing factor SPF27; Snt309; SPF27; spliceosome associated protein, amplified in breast cancer; spliceosome-associated protein SPF 27
6430539P16Rik; AI132645; BCAS2; C76366; C80030; DAM1; Snt309; SPF27